Treatment of Latent Tuberculosis in Socially Marginalised Citizens

NCT03266991 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

22

Enrollment

OTHER

Sponsor class

Stopped Recruitment issues

Conditions

Compliance, Patient

Interventions

DRUG: Rifapentine
DRUG: Isoniazid

Sponsor

Aarhus University Hospital